This week we speak with Professor James Cnota of Cincinnati Children's Hospital about a recent report he co-authored from the SVR trial regarding the impact of tricuspid regurgitation (TR) on outcomes in hypoplastic left heart syndrome (HLHS). How common is TR seen in the HLHS patient and how does this change over time after surgical palliations? Is there an optimal time to intervene on the tricuspid valve in this patient group? What does the future hold for tricuspid surgical interventions? Dr. Cnota has the answers this week.
doi: 10.1007/s00246-025-04122-x